secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001104659-22-086142
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anzu Special Acquisition loses CFO, GC, two board members including chair; Nasdaq non-compliance triggered
--------------------------------------------------------------------------------

- CFO John Joy and GC Peter Ganz resigned July 29-31, 2022; Joy effective after Q2 10-Q filing, Ganz effective July 31.
- Board members Teresa Harris (July 29) and Chairman William Wulfsohn (July 31) resigned citing disagreement with company decisions, pursuit of a specific target, and loss of executives.
- Resignations reduce board from 5 to 3; Nasdaq notified of non-compliance with audit committee independence rule (Listing Rule 5605(c)(2)(A)).
- Company has no pending letter of intent and no assurance of completing a business combination; cure period available for Nasdaq compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/0001104659-22-086142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/tm2222543d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-086142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer